0001578563-24-000320.txt : 20240625
0001578563-24-000320.hdr.sgml : 20240625
20240625160858
ACCESSION NUMBER: 0001578563-24-000320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240624
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VARKI PAUL
CENTRAL INDEX KEY: 0001677896
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 241069014
MAIL ADDRESS:
STREET 1: 600 LEE ROAD
STREET 2: SUITE 100
CITY: WAYNE
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-06-24
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001677896
VARKI PAUL
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
0
1
0
0
Chief Legal Officer
0
Stock Option (Right to Buy)
13.43
2024-06-24
4
A
0
150000
0
A
2034-06-24
Common Stock
150000
150000
D
Twenty-five percent (25%) of the Option Shares vest on June 24, 2025 and the remainder of the Option Shares will vest in equal monthly installments on the first day of each month thereafter over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date.
/s/ Donald R. Reynolds, by Power of Attorney
2024-06-25